SMTL ID : 7qf1.1

Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-2-2-2-mer

Ligands

1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-BMA.1: 3 residues within 4Å: Chain A: N.13, F.37 Chain E: D.1 5 PLIP interactions: 2 interactions with chain A, 3 interactions with chain E Hydrophobic interactions: A:F.37 Hydrogen bonds: A:N.13, E:D.1, E:D.1, E:D.1

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 3 residues within 4Å: Chain B: N.13, F.37 Chain C: D.1 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:D.1, C:D.1, C:D.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Planchais, C. et al., Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2. J.Exp.Med. (2022)

Release Date

2022-05-18

Peptides

Spike protein S1: AB
CV2.6264 light chain: CE
CV2.6264 heavy chain: DF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
F

C
B

E
D

D
C

F
E

Spike protein S1

CV2.6264 light chain

CV2.6264 heavy chain

Related Entries With Identical Sequence